Skip to main content
Premium Trial:

Request an Annual Quote

Multiple Myeloma Foundation Commits $5M to Precision Medicine

CHICAGO (GenomeWeb) – The Multiple Myeloma Research Foundation will invest $5 million over the next three years in an effort to boost precision medicine's profile among clinicians and patients.

The Norwalk, Connecticut-based organization today announced the launch of the MMRF Answer Fund, which seeks to support the development of better ways to identify and treat patients at high risk for multiple myeloma. To this end, the MMRF today issued a request for research projects that rely on data from the ongoing MMRF CoMMpass study, to be paid for by the new fund.

The MMRF Answer Fund will also crowdsource questions from patients, clinicians, and researchers in an effort to pinpoint the "most pressing challenges they face in maximizing clinical outcomes for every patient in this era of precision medicine," the organization said. In the fall, the MMRF will issue another request for applications to find researchers to answer these questions.

"The MMRF CoMMpass Study gives us an incredible quantity of world-class data from which we can glean insights to solve the most urgent questions facing myeloma patients,” MMRF President and CEO Paul Giusti said in a statement. "By getting to the heart of these questions, we will accelerate precision medicine approaches to optimize care and to extend the life of every patient."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.